The PharmAla

PharmAla Biotech Holdings Inc. is a Canadian biotechnology company focused on the research, development, manufacturing, and supply of clinical-grade MDMA and related MDXX class molecules for use in regulated research and therapeutic settings. The company was founded with the goal of alleviating the global shortage of generic, clinical-grade MDMA to... support clinical trials and develop novel compounds with improved safety profiles, using a regulatory-first approach that emphasizes compliance with health authorities. PharmAla works with established laboratories across Canada to produce its products under Good Manufacturing Practice (GMP) standards and is involved in preclinical research and partnerships aimed at expanding access to its therapies in select jurisdictions.Read More